论文部分内容阅读
血防—846是一种广谱抗吸虫病药物。在我省已广泛用于血吸虫病治疗,取得了一定疗效,但也存在着一定的毒性反应,近年来在四川、广东、广西、湖南、湖北、浙江、安庆等地相继报导因服用血防—846引起急性溶血反应的病例,其发生率虽在万分之1—2左右,但由于认识不足,未能及时抢救等原因而造成死亡,对于本药的推广应用有一定影响。为了探讨急性溶血反应及其规律和发生原因,为今后的预防和治疗提供依据,我们在广汉、什邡、棉竹与新都四个县对自1965—1974年来发生溶血反应的病人进行了如下的调查研究。
Blood-846 is a broad-spectrum anti-tuberculosis drug. In our province has been widely used in the treatment of schistosomiasis, and achieved a certain effect, but there are also some toxic reactions in recent years in Sichuan, Guangdong, Guangxi, Hunan, Hubei, Zhejiang, Anqing and other places have been reported due to taking blood-846 Acute hemolytic reaction caused by the case, although the incidence of 1 in ten thousandths or so, but due to lack of understanding, failed to timely rescue and other causes of death, for the promotion of the drug have a certain impact. In order to explore the acute hemolytic reaction and its causes and causes, provide the basis for future prevention and treatment, we in Guanghan, Shifang, cotton bamboo and Xindu four counties from 1965 to 1974 hemolysis patients were as follows Research.